-
-
-
7 . Periodical
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
- 저자
- by Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu, et al.
- 소스
- The Lancet Gastroenterology & Hepatology; February 2022, Vol. 7 Issue: 2 p128-140, 13p
-
7 . Periodical
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
- 저자
- by Vermeire, Severine; Lakatos, Peter L; Ritter, Timothy; Hanauer, Stephen; Bressler, Brian, et al.
- 소스
- The Lancet Gastroenterology & Hepatology; January 2022, Vol. 7 Issue: 1 p28-37, 10p